Fulminant Clostridium difficile-associated pouchitis with a fatal outcome

Nature Reviews Gastroenterology and Hepatology

Volumn 6, Issue 8, 2009, Pages 492-495

  Shen, Bo ^a   Remzi, Feza H ^a   Fazio, Victor W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; COCODAMOL; FAMOTIDINE; FENTANYL; GENTAMICIN; HEPARIN; HYDROCODONE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; HYDROCORTISONE; LOPERAMIDE; METRONIDAZOLE; NARCOTIC ANALGESIC AGENT; PARACETAMOL; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; VANCOMYCIN;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; ASCITES; CASE REPORT; CLOSTRIDIUM DIFFICILE INFECTION; CONSERVATIVE TREATMENT; DIARRHEA; DISSEMINATED INTRAVASCULAR CLOTTING; FATALITY; FECES ANALYSIS; FEMALE; HEMODIALYSIS; HUMAN; HYPOTENSION; ILEITIS; ILEOANAL ANASTOMOSIS; ILEOSTOMY; ILEUS; LEUKOCYTE; MENTAL DISEASE; NASOGASTRIC TUBE; OLIGURIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REHYDRATION; RESPIRATORY FAILURE; RESPIRATORY TRACT INTUBATION; SEPSIS; SEPTIC SHOCK; SINGLE DRUG DOSE; SMALL INTESTINE DISEASE; TACHYCARDIA; ULCERATIVE COLITIS; VOMITING;

CLOSTRIDIUM DIFFICILE; COLITIS, ULCERATIVE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FATAL OUTCOME; FEMALE; HUMANS; ILEOSTOMY; MIDDLE AGED; POUCHITIS; PSEUDOMONAS INFECTIONS;

EID: 68449101065     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2009.105     Document Type: Article

References (14)

1. Mann, S. D., Pitt, J., Springall, R. G. & Thillainayagam, A. V. Clostridium difficile infection - an unusual cause of refractory pouchitis: Report of a case. Dis. Colon Rectum 46, 267-270 (2003).
2. Shen, B. et al. Clostridium difficile-associated pouchitis. Dig. Dis. Sci. 51, 2361-2364 (2006).
3. Issa, M. et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 5, 345-351 (2007).
4. Shen, B. et al. Clostridium difficile infection in patients with ileal pouch-anal anastomosis. Clin. Gastroenterol. Hepatol. 6 782-788 (2008).
5. Duffy, M. et al. Sulfate-reducing bacteria colonize pouches formed for ulcerative colitis but not for familial adenomatous polyposis. Dis. Colon Rectum 45, 384-388 (2002).
6. Nasmyth, D. G., Godwin, P. G., Dixon, M. F., Williams, N. S. & Johnston, D. Ileal ecology after pouch-anal anastomosis or ileostomy. A study of mucosal morphology, fecal bacteriology, fecal volatile fatty acids, and their interrelationship. Gastroenterology 96, 817-824 (1989).
7. Gosselink, M. P. et al. Eradication of pathogenic bacteria and restoration of normal pouch flora: Comparison of metronidazole and ciprofloxacin in the treatment of pouchitis. Dis. Colon Rectum 47, 1519-1525 (2004).
8. Meyers, S., Mayer, L., Bottone, E., Desmond, E. & Janowitz, H. D. Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology 80, 697-700 (1981).
9. Taylor, R. H., Borriello, S, P. & Taylor, A. J. Isolation of Clostridium difficile from the small bowel. Br. Med. J. (Clin. Res. Ed.) 283, 412 (1981).
10. Vesoulis, Z., Williams, G. & Matthews, B. Pseudomembranous enteritis after proctocolectomy: Report of a case. Dis. Colon Rectum 43 551-554 (2000).
11. Pépin, J., Valiquette, L. & Cossette, B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 173 1037-1042 (2005).
12. Musher, D. M., Logan, N. & Mehendiratta, V. Epidemic Clostridium difficile. N. Engl. J. Med. 354, 1199-2203 (2006).
13. Musher, D. M. et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin. Infect. Dis. 40, 1586-1590 (2005).
14. Issa, M., Ananthakrishnan, A. N. & Bininon, D. G. Clostridium difficile and inflammatory bowel disease. Inflamm. Bowel Dis. 14, 1432-1442 (2008).